CWIAX
Price
$82.03
Change
-$0.56 (-0.68%)
Updated
Jun 3 closing price
Net Assets
151.89B
DGFAX
Price
$34.04
Change
-$0.50 (-1.45%)
Updated
Jun 3 closing price
Net Assets
946.1M
Interact to see
Advertisement

CWIAX vs DGFAX

Header iconCWIAX vs DGFAX Comparison
Open Charts CWIAX vs DGFAXBanner chart's image
CWIAX vs DGFAX Comparison Chart in %
View a ticker or compare two or three
VS
CWIAX vs. DGFAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIAX is a Buy and DGFAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIAX has more cash in the bank: 152B vs. DGFAX (946M). CWIAX pays higher dividends than DGFAX: CWIAX (1.33) vs DGFAX (0.74). CWIAX was incepted earlier than DGFAX: CWIAX (24 years) vs DGFAX (21 years). DGFAX (0.95) is less costly to investors than CWIAX (0.75). CWIAX is a more actively managed with annual turnover of: 44.00 vs. DGFAX (27.00). DGFAX initial investment is less costly to investors than CWIAX (4%) vs CWIAX (4%). CWIAX has a lower initial minimum investment than DGFAX: CWIAX (250) vs DGFAX (1000). CWIAX annual gain was more profitable for investors over the last year : 23.01 vs. DGFAX (15.37). CWIAX return over 5 years is better than : 38.22 vs. DGFAX (2.05).
CWIAXDGFAXCWIAX / DGFAX
Total Expense Ratio0.750.9579%
Annual Report Gross Expense Ratio0.750.9579%
Fund Existence24 years21 years-
Gain YTD16.4142.468665%
Front Load4%5%74%
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets152B946M16,068%
Annual Yield % from dividends1.330.74179%
Returns for 1 year23.0115.37150%
Returns for 3 years55.6748.70114%
Returns for 5 years38.222.051,862%
Returns for 10 years124.1095.06131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JCPRX25.81N/A
N/A
JPMorgan US Large Cap Core Plus R5
OIEIX26.46N/A
N/A
JPMorgan Equity Income A
CSHAX12.60N/A
N/A
NYLI Cushing® MLP Premier Class A
RYBOX63.55N/A
N/A
Rydex Biotechnology A
PSKCX23.22N/A
N/A
Virtus KAR Mid-Cap Growth C